US Patent Issued to Bluefin BioMedicine on Nov. 18 for "Anti-TMEFF1 antibodies and antibody drug conjugates" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,358, issued on Nov. 18, was assigned to Bluefin BioMedicine Inc. (Beverly, Mass.).

"Anti-TMEFF1 antibodies and antibody drug conjugates" was invented by Isabel Milan Chu (Lexington, Mass.), Scott Michael Lonning (Westford, Mass.), Nels Eric Pederson (Mansfield, Mass.), Klarisa Rikova (Reading, Mass.), Aleksandr Tkachev (Cambridge, Mass.) and Jason G. Beaudet (Beverly, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are transmembrane protein with EGF-like and two-follistatin-like domains 1 (TMEFF1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs."

The patent w...